{"id":186943,"date":"2025-11-21T12:13:36","date_gmt":"2025-11-21T11:13:36","guid":{"rendered":"https:\/\/www.gpigroup.com\/?p=186943"},"modified":"2025-11-21T12:13:36","modified_gmt":"2025-11-21T11:13:36","slug":"sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles","status":"publish","type":"post","link":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/","title":{"rendered":"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles."},"content":{"rendered":"<p>Le 12 novembre 2025, au si\u00e8ge de BMedical Systems \u00e0 H\u00f6singen (L), s\u2019est d\u00e9roul\u00e9 le lancement officiel de <strong>Sentinel-Eyes<\/strong>, une solution technologique in\u00e9dite d\u00e9di\u00e9e \u00e0 la gestion \u00e0 distance des Produits Sanguins Labiles. Ce projet, port\u00e9 par <strong>GPI France, SATO, BMedical Systems<\/strong>, marque une \u00e9tape importante dans la modernisation des pratiques transfusionnelles.<\/p>\n<h3>Une ambition commune : s\u00e9curiser et simplifier la transfusion<\/h3>\n<p>Sentinel-Eyes est n\u00e9 d\u2019un constat partag\u00e9 : dans de nombreux \u00e9tablissements, notamment les plus \u00e9loign\u00e9s ou sous-dot\u00e9s, la gestion des produits sanguins labiles (PSL) reste complexe, manuelle et sujette \u00e0 erreurs. En combinant des technologies de pointe \u2013 RFID, r\u00e9frig\u00e9ration m\u00e9dicale, pilotage logiciel \u2013 les partenaires ont imagin\u00e9 une solution compl\u00e8te, interop\u00e9rable et centr\u00e9e sur le patient.<\/p>\n<p>\u00ab<em>Sentinel-Eyes, c\u2019est la rencontre de trois industriels experts avec un objectif commun : innover dans la gestion \u00e0 distance d\u2019une banque de sang.<\/em>\u00bb<br \/>\n\u2014 Michel Angu\u00e9, directeur commercial, GPI France.<\/p>\n<h3>Un dispositif modulaire et intelligent<\/h3>\n<p>Sans tout d\u00e9voiler, Sentinel-Eyes repose sur une infrastructure connect\u00e9e permettant le stockage, l\u2019identification et la mise \u00e0 disposition s\u00e9curis\u00e9e des PSL. Gr\u00e2ce \u00e0 des puces RFID sans batterie (technologie SATO), des r\u00e9frig\u00e9rateurs intelligents (BMedical Systems) et un pilotage logiciel certifi\u00e9 ISO 13485 (Cursus \u2013 GPI France), chaque \u00e9tape du processus est trac\u00e9e, s\u00e9curis\u00e9e et optimis\u00e9e.<\/p>\n<h3>Un lancement plac\u00e9 sous le signe de la collaboration<\/h3>\n<p>Le lancement du 12 novembre a permis de r\u00e9unir les trois industriels, de filmer les \u00e9quipements en conditions r\u00e9elles et de recueillir les t\u00e9moignages des partenaires. Cette journ\u00e9e a aussi \u00e9t\u00e9 l\u2019occasion de valoriser l\u2019approche collaborative qui a permis de faire \u00e9merger une solution robuste, pens\u00e9e pour les professionnels de sant\u00e9.<\/p>\n<p>\u00ab <em>Le couplage avec des r\u00e9frig\u00e9rateurs intelligents garantit une conservation optimale et une tra\u00e7abilit\u00e9 totale des poches de sang.<\/em> \u00bb<br \/>\n\u2014 K\u00e9vin Laville, BMedical Systems<\/p>\n<p>\u00ab <em>Notre technologie RFID PJM permet une identification instantan\u00e9e, sans batterie, avec un marquage lumineux des poches \u00e0 pr\u00e9lever.<\/em> \u00bb<br \/>\n\u2014 Florent Laloux, SATO<\/p>\n<h3>Et maintenant ?<\/h3>\n<p>Sentinel-Eyes sera pr\u00e9sent\u00e9 au congr\u00e8s de la SFTS les 11 et 12 d\u00e9cembre \u00e0 Bruxelles. Deux autres publications suivront pour d\u00e9tailler le fonctionnement de la solution et son approche technologique innovante. Ce premier article pose les bases d\u2019une transformation attendue dans le secteur transfusionnel.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-186956 size-full\" src=\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/2025-GPI-SFTS.jpg\" alt=\"\" width=\"625\" height=\"167\" srcset=\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/2025-GPI-SFTS.jpg 625w, https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/2025-GPI-SFTS-300x80.jpg 300w\" sizes=\"auto, (max-width: 625px) 100vw, 625px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le 12 novembre a marqu\u00e9 le lancement de Sentinel-Eyes. Plongez au c\u0153ur de cette solution connect\u00e9e qui r\u00e9volutionne la s\u00e9curit\u00e9 et la gestion des banques de sang gr\u00e2ce \u00e0 une technologie de pointe.<\/p>\n","protected":false},"author":38,"featured_media":186944,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1414],"tags":[],"class_list":["post-186943","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelle"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles. | GPI<\/title>\n<meta name=\"description\" content=\"Lancement officiel de Sentinel-Eyes par GPI France, SATO et BMedical. Une solution connect\u00e9e in\u00e9dite pour s\u00e9curiser la gestion des produits sanguins labiles.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles. | GPI\" \/>\n<meta property=\"og:description\" content=\"Lancement officiel de Sentinel-Eyes par GPI France, SATO et BMedical. Une solution connect\u00e9e in\u00e9dite pour s\u00e9curiser la gestion des produits sanguins labiles.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/\" \/>\n<meta property=\"og:site_name\" content=\"GPI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/GruppoGPI\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-21T11:13:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png\" \/>\n\t<meta property=\"og:image:width\" content=\"892\" \/>\n\t<meta property=\"og:image:height\" content=\"1122\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Federico Pessot\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Federico Pessot\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/\"},\"author\":{\"name\":\"Federico Pessot\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f\"},\"headline\":\"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles.\",\"datePublished\":\"2025-11-21T11:13:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/\"},\"wordCount\":395,\"publisher\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png\",\"articleSection\":[\"Nouvelle\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/\",\"url\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/\",\"name\":\"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles. | GPI\",\"isPartOf\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png\",\"datePublished\":\"2025-11-21T11:13:36+00:00\",\"description\":\"Lancement officiel de Sentinel-Eyes par GPI France, SATO et BMedical. Une solution connect\u00e9e in\u00e9dite pour s\u00e9curiser la gestion des produits sanguins labiles.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#primaryimage\",\"url\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png\",\"contentUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png\",\"width\":892,\"height\":1122},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.gpigroup.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#website\",\"url\":\"https:\/\/www.gpigroup.com\/fr\/\",\"name\":\"GPI\",\"description\":\"The Healthcare Partner\",\"publisher\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.gpigroup.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#organization\",\"name\":\"GPI S.p.A.\",\"url\":\"https:\/\/www.gpigroup.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg\",\"contentUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg\",\"width\":1946,\"height\":1945,\"caption\":\"GPI S.p.A.\"},\"image\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/GruppoGPI\/\",\"https:\/\/www.linkedin.com\/company\/gpi-spa\",\"http:\/\/www.youtube.com\/user\/GruppoGPI\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f\",\"name\":\"Federico Pessot\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g\",\"caption\":\"Federico Pessot\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles. | GPI","description":"Lancement officiel de Sentinel-Eyes par GPI France, SATO et BMedical. Une solution connect\u00e9e in\u00e9dite pour s\u00e9curiser la gestion des produits sanguins labiles.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/","og_locale":"fr_FR","og_type":"article","og_title":"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles. | GPI","og_description":"Lancement officiel de Sentinel-Eyes par GPI France, SATO et BMedical. Une solution connect\u00e9e in\u00e9dite pour s\u00e9curiser la gestion des produits sanguins labiles.","og_url":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/","og_site_name":"GPI","article_publisher":"https:\/\/www.facebook.com\/GruppoGPI\/","article_published_time":"2025-11-21T11:13:36+00:00","og_image":[{"width":892,"height":1122,"url":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png","type":"image\/png"}],"author":"Federico Pessot","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Federico Pessot","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#article","isPartOf":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/"},"author":{"name":"Federico Pessot","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f"},"headline":"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles.","datePublished":"2025-11-21T11:13:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/"},"wordCount":395,"publisher":{"@id":"https:\/\/www.gpigroup.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png","articleSection":["Nouvelle"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/","url":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/","name":"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles. | GPI","isPartOf":{"@id":"https:\/\/www.gpigroup.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#primaryimage"},"image":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png","datePublished":"2025-11-21T11:13:36+00:00","description":"Lancement officiel de Sentinel-Eyes par GPI France, SATO et BMedical. Une solution connect\u00e9e in\u00e9dite pour s\u00e9curiser la gestion des produits sanguins labiles.","breadcrumb":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#primaryimage","url":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png","contentUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/11\/image.png","width":892,"height":1122},{"@type":"BreadcrumbList","@id":"https:\/\/www.gpigroup.com\/fr\/news\/sentinel-eyes-une-nouvelle-ere-pour-la-gestion-des-produits-sanguins-labiles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gpigroup.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Sentinel-Eyes : une nouvelle \u00e8re pour la gestion des produits sanguins Labiles."}]},{"@type":"WebSite","@id":"https:\/\/www.gpigroup.com\/fr\/#website","url":"https:\/\/www.gpigroup.com\/fr\/","name":"GPI","description":"The Healthcare Partner","publisher":{"@id":"https:\/\/www.gpigroup.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gpigroup.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.gpigroup.com\/fr\/#organization","name":"GPI S.p.A.","url":"https:\/\/www.gpigroup.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg","contentUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg","width":1946,"height":1945,"caption":"GPI S.p.A."},"image":{"@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/GruppoGPI\/","https:\/\/www.linkedin.com\/company\/gpi-spa","http:\/\/www.youtube.com\/user\/GruppoGPI"]},{"@type":"Person","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f","name":"Federico Pessot","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g","caption":"Federico Pessot"}}]}},"_links":{"self":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts\/186943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/comments?post=186943"}],"version-history":[{"count":3,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts\/186943\/revisions"}],"predecessor-version":[{"id":186970,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts\/186943\/revisions\/186970"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/media\/186944"}],"wp:attachment":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/media?parent=186943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/categories?post=186943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/tags?post=186943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}